ES377723A1 - A PROCEDURE FOR PREPARING A PHARMACEUTICAL TABLET. - Google Patents

A PROCEDURE FOR PREPARING A PHARMACEUTICAL TABLET.

Info

Publication number
ES377723A1
ES377723A1 ES377723A ES377723A ES377723A1 ES 377723 A1 ES377723 A1 ES 377723A1 ES 377723 A ES377723 A ES 377723A ES 377723 A ES377723 A ES 377723A ES 377723 A1 ES377723 A1 ES 377723A1
Authority
ES
Spain
Prior art keywords
preparing
pharmaceutical tablet
procedure
pharmacographically
translation
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
ES377723A
Other languages
Spanish (es)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Pfizer Corp Belgium
Original Assignee
Pfizer Corp Belgium
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer Corp Belgium filed Critical Pfizer Corp Belgium
Publication of ES377723A1 publication Critical patent/ES377723A1/en
Expired legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/54—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
    • A61K31/542—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame ortho- or peri-condensed with heterocyclic ring systems
    • A61K31/545—Compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins, cefaclor, or cephalexine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/425—Thiazoles
    • A61K31/429—Thiazoles condensed with heterocyclic ring systems
    • A61K31/43—Compounds containing 4-thia-1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula, e.g. penicillins, penems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Cephalosporin Compounds (AREA)

Abstract

A method of preparing a pharmaceutical tablet suitable for oral administration, characterized by mixing a water-soluble salt of a pharmacographically active acid compound and a pharmaceutically acceptable amino-substituted carboxylic acid. (Machine-translation by Google Translate, not legally binding)
ES377723A 1969-03-20 1970-03-20 A PROCEDURE FOR PREPARING A PHARMACEUTICAL TABLET. Expired ES377723A1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB1467169A GB1291282A (en) 1969-03-20 1969-03-20 Improvements in pharmaceutical compositions

Publications (1)

Publication Number Publication Date
ES377723A1 true ES377723A1 (en) 1972-10-16

Family

ID=10045477

Family Applications (1)

Application Number Title Priority Date Filing Date
ES377723A Expired ES377723A1 (en) 1969-03-20 1970-03-20 A PROCEDURE FOR PREPARING A PHARMACEUTICAL TABLET.

Country Status (6)

Country Link
BE (1) BE747657A (en)
CA (1) CA930305A (en)
DE (1) DE2013040A1 (en)
ES (1) ES377723A1 (en)
FR (1) FR2035119B1 (en)
GB (1) GB1291282A (en)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2211019C3 (en) * 1972-03-08 1980-08-28 Bayer Ag, 5090 Leverkusen Oral penicillin flavor enhancing formulations
US4235900A (en) * 1978-11-15 1980-11-25 E. R. Squibb & Sons, Inc. Cephradine compositions
EP0091502A1 (en) * 1982-04-13 1983-10-19 Asahi Kasei Kogyo Kabushiki Kaisha A pharmaceutical preparation of cephalosporin for rectal administration

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB794798A (en) * 1955-09-22 1958-05-07 Nathaniel Mandel Elias Pharmaceutical compositions

Also Published As

Publication number Publication date
GB1291282A (en) 1972-10-04
FR2035119B1 (en) 1974-08-30
CA930305A (en) 1973-07-17
BE747657A (en) 1970-09-21
FR2035119A1 (en) 1970-12-18
DE2013040A1 (en) 1970-11-26

Similar Documents

Publication Publication Date Title
NL185130C (en) METHOD FOR PREPARING SOLID BISM-HALF PHARMACEUTICAL PREPARATIONS, FORMED PREPARATIONS AND PROCESS FOR PREPARING A THERAPEUTICALLY ACTIVE LIQUID FOR ORAL ADMINISTRATION
NL7506407A (en) PROCESS FOR PREPARING AN ORAL ACTIVE PHARMACEUTICAL PREPARATION.
ES443910A1 (en) Benzoic acids, their derivatives and process for preparing them
NL189898C (en) FIXED, PHARMACEUTICAL DOSAGE FORM FOR ORAL ADMINISTRATION AND METHOD OF MANUFACTURE THEREOF.
JPS5241214A (en) Method of making preparations for oral administration
NL168838C (en) METHOD FOR THE PREPARATION OF COCCIDIOSTATIC AND ANTIBACTERIALLY ACTIVE COMPOUNDS, AND METHOD FOR THE PREPARATION OF A PREPARATION CONTAINING SUCH A COMPOUND AND FORMING PREPARED PREPARATION OF THE PURPOSE.
NL162363C (en) PROCESS FOR PREPARING A MEDICINAL PRODUCT WITH BETA-ENERGY-LOCKING EFFECT THAT A 1-PHENOXY-2-HYDROXY-3-ALKYLAMINOPROPEN DERIVATIVE AND / OR A PHARMACEUTICALLY ACCEPTABLE ACID STOCK PROCESS. PREPARATION OF THESE DERIVATIVES AND THEIR ACID ADDITION SALTS.
NL164472C (en) METHOD FOR PREPARING A PHARMACEUTICAL PREPARATION SUITABLE FOR ORAL ADMINISTRATION, SUITABLE FOR THE TREATMENT OF OESOPHAGITIS AND ARTICLES OBTAINED THEREOF.
NL157006B (en) METHOD FOR PREPARING ANTI-INFLAMMATIC ACTIVE PHENOXYPHENYLACACIC ACID DERIVATIVES AND PHARMACEUTICAL PREPARATION CONTAINING THIS COMPOUND
ES360952A1 (en) Procedure for the preparation of sulfonilurea derivatives. (Machine-translation by Google Translate, not legally binding)
HU175933B (en) Process for producing 4-hydroxy-3,5-dialkyl-phenyl-propionic acid derivatives and pharmaceutical compositions containing ttem as active agents
ES410825A1 (en) Quinoline derivatives
NL148611B (en) PROCESS FOR THE PREPARATION OF THERAPEUTICALLY ACTIVE DERIVATIVES OF 7-AMINOCEPHALOSPORANIC ACID, PROCESS FOR PREPARING PHARMACEUTICAL PREPARATIONS AND PREPARED PRODUCTS SO OBTAINED.
NL168210B (en) A PROCESS FOR THE PREPARATION OF PHARMACEUTICAL PREPARATIONS AND A PROCESS FOR THE PREPARATION OF CYCLIC CARBONIC ACID DERIVATIVES.
FI48974C (en) A method for stabilizing a pharmaceutical preparation containing basic dihydrodibenzazepine suitable for oral administration.
NL152755B (en) METHOD OF PREPARING A MEDICINAL PRODUCT WITH ANTI-BACTERIAL ACTION SUITABLE FOR ORAL ADMINISTRATION CONTAINING RIFAMPICIN AND A SYNERGISTICALLY ACTING HETEROCYCLICAL COMPOUND AND PREPARED BY THIS METHOD.
DOP1979002763A (en) A METHOD FOR PREPARING A TABLET OF A PHARMACEUTICAL FORMULATION
ES377725A1 (en) Improvements in pharmaceutical compositions
NL175292C (en) METHOD FOR PREPARING OR MANUFACTURING A PHARMACEUTICAL PREPARATION WITH ANALGETIC ACTION, AND A METHOD FOR PREPARING A 2-AMINOTETRALINE DERIVATIVE OR A PHARMACEUTICALLY ACCEPTABLE ACID SALT THEREOF
NL164552B (en) METHOD FOR PREPARING A PHARMACEUTICAL PREPARATION; FORMED PHARMACEUTICAL PREPARATION; METHOD FOR PREPARING MEDICINAL COMPOUNDS.
NL166018C (en) PROCESS FOR THE PREPARATION OF A PHARMACEUTICAL PREPARATION, AND FOR PREPARATIONS PREPARED USING THIS PROCESS AND METHOD FOR PREPARING SUITABLE COMPOUNDS.
IL37586A0 (en) Indolylacetic acid derivatives and salts thereof,processes for their preparation and pharmaceutical compositions containing the same
NL149177B (en) PROCESS FOR PREPARING THERAPEUTICALLY ACTIVE THIAZOLO-PYRIMIDINE COMPOUNDS, PROCESS FOR PREPARING A THERAPEUTIC PREPARATION AND FORMED PHARMACEUTICAL PREPARATIONS THEREFORE OBTAINED.
CA937866A (en) Process for the manufacture of a drug dosage form permitting controlled release of active ingredient
NL165932B (en) METHOD FOR PREPARING AN ANTI-INFLAMMATORY ACTIVE PHARMACEUTICAL PREPARATION, AND METHOD FOR PREPARING A 2-ARYLTHIAZOL-4-YL DERIVATIVE OF AN ALIPHATIC CARBONIC ACID